Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Early Phase 1
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Early Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07108296Not Yet Recruiting

A Study on Cardiopulmonary Exercise Tolerance Standards for Healthy Chinese Population

Role: lead

NCT06320249Not ApplicableNot Yet Recruiting

Rotation-traction Manipulation of Different Treatment Frequency in Cervical Radiculopathy

Role: collaborator

NCT02958020Recruiting

Multicenter Cohort Study on Osteoporosis

Role: collaborator

NCT04711980Early Phase 1Unknown

Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy

Role: collaborator

NCT03478332Phase 2Unknown

Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease

Role: lead

All 5 trials loaded